| Year |
Citation |
Score |
| 2020 |
Janda E, Nepveu F, Calamini B, Ferry G, Boutin JA. Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme. Molecular Pharmacology. 98: 620-633. PMID 32913139 DOI: 10.1124/Molpharm.120.000105 |
0.307 |
|
| 2016 |
Shen K, Calamini B, Fauerbach JA, Ma B, Shahmoradian SH, Serrano Lachapel IL, Chiu W, Lo DC, Frydman J. Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract. Elife. 5. PMID 27751235 DOI: 10.7554/Elife.18065 |
0.404 |
|
| 2016 |
Rinkenbaugh AL, Cogswell PC, Calamini B, Dunn DE, Persson AI, Weiss WA, Lo DC, Baldwin AS. IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance. Oncotarget. PMID 27732951 DOI: 10.18632/Oncotarget.12507 |
0.301 |
|
| 2014 |
Yu A, Shibata Y, Shah B, Calamini B, Lo DC, Morimoto RI. Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition. Proceedings of the National Academy of Sciences of the United States of America. 111: E1481-90. PMID 24706768 DOI: 10.1073/Pnas.1321811111 |
0.592 |
|
| 2014 |
Shen K, Calamini B, Lo D, Frydman J. Polyglutamine Flanking Regions in Huntingtin Highlight Key Structural Intermediates Relevant for Molecular Chaperone Interaction and Huntington's Disease Pathogenesis Biophysical Journal. 106: 682a. DOI: 10.1016/J.Bpj.2013.11.3774 |
0.391 |
|
| 2013 |
St John SE, Jensen KC, Kang S, Chen Y, Calamini B, Mesecar AD, Lipton MA. Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2. Bioorganic & Medicinal Chemistry. 21: 6022-37. PMID 23953689 DOI: 10.1016/J.Bmc.2013.07.037 |
0.372 |
|
| 2013 |
Bersuker K, Hipp MS, Calamini B, Morimoto RI, Kopito RR. Heat shock response activation exacerbates inclusion body formation in a cellular model of Huntington disease. The Journal of Biological Chemistry. 288: 23633-8. PMID 23839939 DOI: 10.1074/Jbc.C113.481945 |
0.574 |
|
| 2013 |
Calamini B, Lo DC, Kaltenbach LS. Experimental models for identifying modifiers of polyglutamine-induced aggregation and neurodegeneration. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 400-15. PMID 23700210 DOI: 10.1007/S13311-013-0195-4 |
0.406 |
|
| 2012 |
Calamini B, Morimoto RI. Protein homeostasis as a therapeutic target for diseases of protein conformation. Current Topics in Medicinal Chemistry. 12: 2623-40. PMID 23339312 DOI: 10.2174/1568026611212220014 |
0.589 |
|
| 2012 |
Calamini B, Silva MC, Madoux F, Hutt DM, Khanna S, Chalfant MA, Saldanha SA, Hodder P, Tait BD, Garza D, Balch WE, Morimoto RI. Small-molecule proteostasis regulators for protein conformational diseases. Nature Chemical Biology. 8: 185-96. PMID 22198733 DOI: 10.1038/Nchembio.763 |
0.568 |
|
| 2010 |
Calamini B, Ratia K, Malkowski MG, Cuendet M, Pezzuto JM, Santarsiero BD, Mesecar AD. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. The Biochemical Journal. 429: 273-82. PMID 20450491 DOI: 10.1042/Bj20091857 |
0.348 |
|
| 2008 |
Calamini B, Santarsiero BD, Boutin JA, Mesecar AD. Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2. The Biochemical Journal. 413: 81-91. PMID 18254726 DOI: 10.1042/Bj20071373 |
0.32 |
|
| Show low-probability matches. |